Michael K. Dalton

Michael K. Dalton

Auto-generated profile, based on publicly available information

Michael K. Dalton

Center for Surgery and Public Health, Harvard Medical School, Harvard T. H. Chan School of Public Health, Department of Surgery, Brigham and Women’s Hospital; Boston, MA

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 October 2021 in JAMA Surgery
Verified
Journal Article
Open access
PDF file
MDMichael K. Dalton
Michael K. Dalton
KRKyle N. Remick
Kyle N. Remick
MMMichael Mathias
Michael Mathias
QTQuoc-Dien Trinh
Quoc-Dien Trinh
ZCZara Cooper
Zara Cooper
JWJoel S. Weissman
Joel S. Weissman
As the intensity of fighting in current conflicts has declined, military surgeons are getting less experience treating combat casualties, leading to concerns about the state of the military trauma system and the readiness of military surgeons. This concern has been noted in the popular press, leading to headlines such as “Military Health System Isn’t Ready for Battlefield Injuries.”1

16 August 2019 in Journal of Trauma and Acute Care Surgery
Verified
Journal Article
Closed access
AGAnna Do Goldenberg
Anna Do Goldenberg
DRDeviney Rattigan
Deviney Rattigan
MDMichael Dalton
Michael Dalton
JGJohn P. Gaughan
John P. Gaughan
JTJ. Scott Ma Thomson
J. Scott Ma Thomson
JHJoshua P. Do Hazelton
Joshua P. Do Hazelton
BACKGROUND: Shorter prehospital time in patients sustaining penetrating trauma has been shown to be associated with improved survival. Literature has also demonstrated that police transport (vs. Emergency Medical Services [EMS]) shortens transport times to a trauma center. The purpose of this study was to determine if ShotSpotter, which triangulates the location of gunshots and alerts police, expedited dispatch and transport of injured victims to the trauma center. METHODS: All shootings which occurred in Camden, NJ, from 2010 to 2018 were reviewed. Demographic, geographic, response time, transport time, and field intervention data were collected from medical and police records. We compared shootings where the ShotSpotter was activated versus shootings where ShotSpotter was not activated. Incidents, which did not occur in Camden or where complete data were not available, were excluded as were patients not transported by police or EMS. RESULTS: There were 627 shootings during the study period which met inclusion criteria with 190 (30%) activating the ShotSpotter system. Victims involved in shootings with ShotSpotter activation were more severely injured, more likely to be transported by police, less likely to undergo trauma bay resuscitative measures, and more likely to receive blood products. Mortality, when adjusted for distance, Trauma, and Injury Severity Score, Injury Severity Score, and shock index, was not significantly different between ShotSpotter and non-ShotSpotter incidents. ShotSpotter activation significantly reduced both the response time as well as transport time for both police and EMS (all p < 0.05). CONCLUSION: The activation of the ShotSpotter technology increased the likelihood of police transport of gunshot victims. Furthermore, the use of this technology resulted in shorter response times as well as transport times for both police and EMS. This technology may be beneficial in enhancing the care of victims of penetrating trauma. LEVEL OF EVIDENCE: Therapeutic/Care management, level III.

1 November 2016 in The American Journal of Surgery
Verified
Journal Article
Closed access
MDMichael K. Dalton
Michael K. Dalton
EMElizabeth McDonald
Elizabeth McDonald
PBPulkesh Bhatia
Pulkesh Bhatia
KDKimberly A. Davis
Kimberly A. Davis
KSKevin M. Schuster
Kevin M. Schuster

1 October 2020 in Surgery
Verified
Journal Article
Closed access
MDMichael K. Dalton
Michael K. Dalton
MCMuhammad Ali Chaudhary
Muhammad Ali Chaudhary
TATomas Andriotti
Tomas Andriotti
DSDaniel Sturgeon
Daniel Sturgeon
PLPeter A. Learn
Peter A. Learn
EGEric Goralnick
Eric Goralnick

1 May 2021 in Military Medicine
Verified
Journal Article
Open access
PDF file
MCMuhammad Ali Chaudhary
Muhammad Ali Chaudhary
MDMichael K Dalton
Michael K Dalton
TKTracey P Koehlmoos
Tracey P Koehlmoos
ASAndrew Schoenfeld
Andrew Schoenfeld
EGEric Goralnick
Eric Goralnick
Introduction: Total hip arthroplasty and total knee arthroplasty account for over 1 million procedures annually. Opioids are the mainstay of postoperative pain management for these patients. In this context, the objective of this study was to determine patterns of use and factors associated with early discontinuation of opioids after total joint arthroplasty (TJA). Methods: TRICARE claims data (2006-2014) were queried for adult (18-64 years) patients who underwent total hip arthroplasty or total knee arthroplasty. Prescription opioid use was identified from 6 months before and 6 months after surgical intervention. Prior opioid use was categorized as naïve, exposed (with non-sustained use), and sustained (6 month continuous use before surgery). Cox proportional-hazards models were used to identify factors associated with opioid discontinuation following TJA. Results: Among the 29,767 patients included in the study, 15,271 (51.3%) had prior opioid exposure and 3,740 (12.5%) were sustained opioid users. At 6 months after the surgical intervention, 3,171 (10.6%) continued opioid use, 3.3% were among opioid naïve, 10.2% among exposed, and 33.3% among sustained users. In risk-adjusted models, prior opioid exposure (hazards ratio: 0.65, 95% CI: 0.62-0.67) and sustained prior use (hazards ratio: 0.33, 95% CI: 0.31-0.35) were the strongest predictors of lower likelihood of opioid discontinuation. Lower socio-economic status, depression, and anxiety were also strong predictors. Conclusion: Prior opioid exposure was strongly associated with continued opioid dependence after TJA. Although one-third of prior sustained users continued use after surgery, approximately 10% of previously exposed patients became sustained users, making them the prime candidates for targeted interventions to reduce the likelihood of sustained opioid use after TJA.

4 October 2021 in Health Services Research
Verified
Journal Article
Open access
PDF file
CZCheryl K. Zogg
Cheryl K. Zogg
JLJudith H. Lichtman
Judith H. Lichtman
MDMichael K. Dalton
Michael K. Dalton
PLPeter A. Learn
Peter A. Learn
ASAndrew Schoenfeld
Andrew Schoenfeld
ZCZara Cooper
Zara Cooper
Objective: Ongoing health care reforms within the US Military Health System (MHS) are expected to shift >1.9 million MHS beneficiaries from military treatment facilities (MTFs) into local civilian hospitals over the next 1–2 years. The objective of this study was to examine how such health care reforms are likely to affect the quality of MHS care.Data sources: Adult MHS beneficiaries, aged 18–64 years, treated in MTFs (under a program known as Direct Care) were compared against (1) MHS beneficiaries treated in locally available civilian hospitals (under a program known as Purchased Care) and (2) similarly‐aged adult civilian patients across the United States. MHS beneficiaries in Direct and Purchased Care were identified from fiscal‐year 2016–2018 MHS inpatient claims. National inpatients were identified in the 2017 Nationwide Readmissions Database.Study design: Retrospective cohort.Data collection: Differences in quality were compared using two sets of quality metrics endorsed by the US Agency for Healthcare Research and Quality (AHRQ): Inpatient Quality Indicators, 19 quality metrics that look at differences in in‐hospital mortality, and Patient Safety Indicators, 18 quality metrics that look at differences in in‐hospital morbidity and adverse events. Among MHS beneficiaries (Direct and Purchased Care), we further simulated what changes in quality indicators might look like under various proposed scenarios of reduced access to Direct Care.Principal findings: A total of 502,252 MHS admissions from 37 MTFs and surrounding civilian hospitals were included (326,076 Direct Care, 179,176 Purchased Care). Nationwide, 9.34 million adult admissions from 2453 hospitals were included. On average, MHS beneficiaries treated in MTFs experienced better inpatient quality and improved patient safety compared with MHS beneficiaries treated in locally available civilian hospitals (e.g., summary observed‐to‐expected ratio for medical mortality: 0.98 vs. 1.03, p < 0.001) and adult patients across the United States (0.98 vs. 1.02, p < 0.001). Simulations of proposed changes resulted in consistently worse outcomes for MHS patients, whether reducing MTF access by 10%, 20%, or 50% nationwide; limiting MTF access to active‐duty beneficiaries; or closing MTFs with the worst performance on patient safety (p < 0.001 for overall quality indicators for each).Conclusions: Reducing access to MTFs could result in significant harm to MHS patients. The results underscore the importance of health‐policy planning based on evidence‐based evaluation and the need to consider the consequential downstream effects caused by changes in access to care.